SCHEMBL22072500

SCHEMBL22072500

CC(O)c1oc2c(O)c(O)c(O)c(O)c2c1C(=O)c1cc(Br)c(O)c(Br)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EYA3 Q99504 4/20 0.58
▸ CYP2C19 P33261 2/20 0.41
▸ SLC22A12 Q96S37 11/20 0.41
▸ TTR P02766 5/20 0.41
▸ CYP2C9 P11712 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ EYA2 O00167 1/20 0.39
▸ ABCC4 O15439 1/20 0.39
▸ PLIN1 O60240 1/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ABCB11 O95342 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ALB P02768 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ NR3C1 P04150 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ PGR P06401 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22072522 0.86 EYA3 (0.45) EYA3CYP2C19SLC22A12TTRCYP2C9
SCHEMBL20718288 0.83 EYA3 (0.55) EYA3CYP2C19SLC22A12TTRCYP2C9
SCHEMBL22680471 0.82 EYA3 (0.54) EYA3CYP2C19SLC22A12TTRCYP2C9
SCHEMBL20718531 0.79 EYA3 (0.51) EYA3CYP2C19SLC22A12TTRCYP2C9
SCHEMBL26211199 0.79 CYP2C19 (0.41) EYA3CYP2C19SLC22A12TTRALDH1A1
SCHEMBL26211957 0.78 EYA3 (0.42) EYA3CYP2C19SLC22A12TTRCYP2C9
SCHEMBL24266787 0.77 EYA3 (0.36) EYA3CYP2C19SLC22A12TTRCYP2C9
SCHEMBL24267018 0.77 EYA3 (0.36) EYA3CYP2C19SLC22A12TTR
SCHEMBL26211318 0.77 SLC22A12 (0.57) EYA3CYP2C19SLC22A12TTRCYP2C9
SCHEMBL20718366 0.76 EYA3 (0.59) EYA3CYP2C19SLC22A12TTRCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3957629-B1 PROCESS FOR MAKING DEUTERATED HYDROXY-BENZBROMARONE AND INTERMEDIATES THEREOF ARTHROSI THERAPEUTICS INC (US) 2023-09-06 — — EP disclosed
WO-2023125667-A1 PREPARATION OF A COMPOUND FOR THE TREATMENT OF GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2023-07-06 — — WO disclosed
WO-2023098872-A1 CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2023-06-08 — — WO disclosed
WO-2020118114-A1 METHODS FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2020-06-11 — — WO disclosed
WO-2020118113-A1 CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2020-06-11 — — WO disclosed
Send feedback